{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:23:15Z","timestamp":1790191395474,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>BNCT is a radiotherapeutic method for cancer treatment that uses tumor-targeting 10B-compounds. BNCT for cutaneous melanoma using BPA, a phenylalanine derivative, was first initiated by Mishima et al. in 1987. This article reviews the radiobiological basis of melanoma control and damage to normal tissues as well as the results of clinical studies. Experimental studies showed that the compound biological effectiveness (CBE) values of the 10B (n, \u03b1)7Li reaction for melanoma control ranged from 2.5 to 3.3. The CBE values of the 10B (n, \u03b1)7Li reaction for skin damage ranged from 2.4 to 3.7 with moist desquamation as the endpoint. The required single radiation dose for controlling human melanoma was estimated to be 25 Gy-Eq or more by analyzing the 50% tumor control dose data of conventional fractionated radiotherapy. From the literature, the maximum permissible dose to human skin by single irradiation was estimated to be 18 Gy-Eq. With respect to the pharmacokinetics of BPA in patients with melanoma treated with 85\u2013350 mg\/kg BPA, the melanoma-to-blood ratio ranged from 2.1\u20133.8 and the skin-to-blood ratio was 1.31 \u00b1 0.22. Good local tumor control and long-term survival of the patients were achieved in two clinical trials of BNCT conducted in Japan.<\/jats:p>","DOI":"10.3390\/cells10112881","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T23:49:52Z","timestamp":1635292192000},"page":"2881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using 10B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results"],"prefix":"10.3390","volume":"10","author":[{"given":"Hiroshi","family":"Fukuda","sequence":"first","affiliation":[{"name":"Department of Radiology, Tohoku Medical and Pharmaceutical University, Sendai 983-8536, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00005072-197204000-00005","article-title":"Neuropathologic Study of Fourteen Cases of Malignant Brain Tumor Treated by Boron-10 Slow Neutron Capture Radiation","volume":"31","author":"Asbury","year":"1972","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_2","unstructured":"Hatanaka, H. (1986). Clinical experience of boron-neutron capture therapy for gliomas: A comparison with conventional chemo-immuno-radiotherapy. Boron Neutron Capture Therapy for Tumors, Nishimura."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0749.1989.tb00196.x","article-title":"New thermal neutron capture therapy for malignant melanoma: Melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial","volume":"2","author":"Mishima","year":"1989","journal-title":"Pigment. Cell Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","article-title":"Treatment of malignant melanoma by single neutron capture treatment with melanoma-seeking 10B-compound","volume":"334","author":"Mishima","year":"1989","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.apradiso.2004.05.059","article-title":"Effectiveness of BNCT for recurrent head and neck malignancies","volume":"61","author":"Kato","year":"2004","journal-title":"Appl. Radiat. Isot."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hed.20418","article-title":"First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET","volume":"28","author":"Aihara","year":"2006","journal-title":"Head Neck"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10147-013-0580-3","article-title":"Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck","volume":"19","author":"Aihara","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_8","unstructured":"McGovern, V.J., and Russell, P. (1973). Neutron capture treatment of malignant melanoma using 10B-chlorpromazine compound. Pigment Cell, Volume 1: Mechanisms in Pigmentation, S. Karger."},{"key":"ref_9","unstructured":"Hatanaka, H. (1986). Chemical behavior of dopaborate and 10B-p-boronophenylalanine. Neutron Capture Therapy, Nishimura."},{"key":"ref_10","first-page":"234","article-title":"Capture of p-boronophenylalanine in malignant melanoma cells by complex formation with melanin monomers, DOPA, DHI and DHICA. BPA trapping mechanism","volume":"Volume II","author":"Larsson","year":"1997","journal-title":"Advances in Neutron Capture Therapy"},{"key":"ref_11","first-page":"573","article-title":"Thermal neuron capture therapy of malignant melanoma: In vitro radiobiological analysis","volume":"37","author":"Nakanishi","year":"1980","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1523-1747.ep12506489","article-title":"Specific killing effect of 10B-paraboronophenylalanine in thermal neutron capture therapy of malignant melanoma: In vitro radiobiological evaluation","volume":"78","author":"Ichihashi","year":"1982","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2307\/3575817","article-title":"Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy","volume":"91","author":"Kobayashi","year":"1982","journal-title":"Radiat. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0167-5087(83)90082-0","article-title":"Microanalysis of ppm-order 10B concentration in tissue for neutron capture therapy by prompt gamma-ray spectrometry","volume":"204","author":"Kobayashi","year":"1982","journal-title":"Nucl. Inst. Method."},{"key":"ref_15","first-page":"167","article-title":"RBE of a thermal neutron beam and the 10B(n, \u03b1) 7Li reaction on cultured B-16 melanoma cells","volume":"51","author":"Fukuda","year":"1987","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0749.1989.tb00207.x","article-title":"Acute and subacute toxicity of 10B-paraboronophenylalanine","volume":"2","author":"Taniyama","year":"1989","journal-title":"Pigment. Cell Res."},{"key":"ref_17","first-page":"127","article-title":"Improvement of solubility of p-boronophenylalanine by complex formation with monosaccarides","volume":"165","author":"Yoshino","year":"1989","journal-title":"Strahlenther Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0749.1989.tb00222.x","article-title":"Estimation of absorbed dose in the covering skin of human melanoma treated by neutron capture therapy","volume":"2","author":"Fukuda","year":"1989","journal-title":"Pigment. Cell Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2307\/3578693","article-title":"Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin","volume":"138","author":"Fukuda","year":"1994","journal-title":"Radiat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mishima, Y. (1996). Selective thermal neutron capture therapy of cancer cells using their specific metabolic activities-Melanoma as prototype. Cancer Neutron. Capture Therapy, Plenum Press.","DOI":"10.1007\/978-1-4757-9567-7"},{"key":"ref_21","first-page":"257","article-title":"Human melanoma treated by boron neutron capture therapy: Comparison of the clinical response with the predicted response","volume":"14","author":"Hiratsuka","year":"1996","journal-title":"Radiat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mishima, Y. (1996). BNCT of malignant melanoma\u2014Radiobiological analysis and data comparison with conventional radiotherapy. Cancer Neutron. Capture Therapy, Plenum Press.","DOI":"10.1007\/978-1-4757-9567-7"},{"key":"ref_23","unstructured":"Allen, B.J., Moore, D.E., and Harrington, B.V. (1996). Tolerance limits of the normal skin treated by single thermal neutron capture therapy. Progress in Neutron Capture Therapy, Plenum Press."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03178777","article-title":"Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor","volume":"26","author":"Fukuda","year":"2003","journal-title":"Australas. Phys. Eng. Sci. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jrr\/rraa068","article-title":"Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)","volume":"61","author":"Hiratsuka","year":"2020","journal-title":"J. Radiat. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2307\/3574048","article-title":"A method for calculating the absorbed dose near-interface from 10B(n, \u03b1)7Li reaction","volume":"61","author":"Kitao","year":"1975","journal-title":"Radiat. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/09553002.2014.942013","article-title":"Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines","volume":"91","author":"Rossini","year":"2015","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0749.1989.tb00219.x","article-title":"RBEs of thermal neutron capture therapy and 10B(n, \u03b1)7Li reaction on melanoma-bearing hamsters","volume":"2","author":"Hiratsuka","year":"1989","journal-title":"Pigment. Cell Res."},{"key":"ref_29","unstructured":"Hall, E.J. (1988). 4. Model tumor system. Radiobiology for the Radiobiologist, Lippincott. [3rd ed.]."},{"key":"ref_30","first-page":"6313","article-title":"Boron neutron capture therapy of murine melanoma","volume":"48","author":"Coderre","year":"1988","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/3578135","article-title":"Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: Dose-response analysis using a morbidity index","volume":"128","author":"Coderre","year":"1991","journal-title":"Radiat. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(93)90533-2","article-title":"Derivation of relative biological effectiveness for the high-LET radiations produced during boron neutron capture irradiation of the 9L rat gliosarcoma in vitro and in vivo","volume":"27","author":"Coderre","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1349-7006.2000.tb00885.x","article-title":"The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice","volume":"91","author":"Suzuki","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_34","first-page":"867","article-title":"The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiological study","volume":"12","author":"Overgaad","year":"1986","journal-title":"Radiother. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2307\/3578136","article-title":"The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster","volume":"128","author":"Hiratsuka","year":"1991","journal-title":"Radiat. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0167-8140(94)90101-5","article-title":"Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium","volume":"32","author":"Morris","year":"1994","journal-title":"Radiother. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0360-3016(82)90061-X","article-title":"Implication of the quadratic cell survival curve and human skin radiation \u201ctolerance dose\u201d on fractionation and super-fractionation dose selection","volume":"8","author":"Douglas","year":"1982","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2307\/3571430","article-title":"Effects of different ionizing radiations on human cells in tissue culture III. Experiments with cyclotron-accelerated alpha-particles and deuterons","volume":"18","author":"Barendsen","year":"1963","journal-title":"Radiat. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/0284186X.2011.582518","article-title":"In vitro RBE-LET dependence for multiple particle types","volume":"50","author":"Overgaard","year":"2011","journal-title":"Acta Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00008390-199902000-00010","article-title":"Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: A study of boron neutron capture therapy for malignant melanoma","volume":"9","author":"Fukuda","year":"1999","journal-title":"Melanoma Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109308","DOI":"10.1016\/j.apradiso.2020.109308","article-title":"Pharmacokinetics of 10B-p-boronophenylalanine (BPA) in the blood and tumors in human patients: A critical review with special reference to tumor-to-blood (T\/B) ratios using resected tumor samples","volume":"166","author":"Fukuda","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00006123-199803000-00004","article-title":"Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in in boron neutron capture therapy","volume":"42","author":"Elowitz","year":"1998","journal-title":"Neurosurgery"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1582-4934.2009.00856.x","article-title":"Eortic 11001: Distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research\/phase 1 trial","volume":"13","author":"Wittig","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.apradiso.2004.05.013","article-title":"Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentine","volume":"61","author":"Lieberman","year":"2004","journal-title":"Appl. Radiat. Isot."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02699940","article-title":"Boron neutron capture therapy for glioblastoma multiforme: Clinical studies in Sweden","volume":"62","author":"Capala","year":"2003","journal-title":"J. Neuro Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109215","DOI":"10.1016\/j.apradiso.2020.109215","article-title":"Biodistribution studies of boronophenylalanine in different types of skin melanoma","volume":"163","author":"Zhang","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"ref_47","unstructured":"Nakagawa, Y., Kobayashi, T., and Fukuda, H. (2006). Neutron irradiation under continuous BPA. Advances in Neuron Capture Therapy 2006, International Society for Neutron Capture."},{"key":"ref_48","unstructured":"Nakagawa, Y., Kobayashi, T., and Fukuda, H. (2006). Successful BNCT for patients with cutaneous and mucosal melanomas: Report of 4 cases. Advances in Neuron Capture Therapy 2006, International Society for Neutron Capture."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"s50","DOI":"10.1016\/j.apradiso.2009.03.020","article-title":"BNCT for skin melanoma in extremities: Updated Argentine clinical results","volume":"67","author":"Roth","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_50","first-page":"60","article-title":"Clinical follow-up of patients with melanoma of the extremity treated in a phase I boron neutron capture therapy protocol","volume":"Volume 1","author":"Larsson","year":"1997","journal-title":"Advances in Neutron Capture Therapy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21147\/j.issn.1000-9604.2016.06.10","article-title":"Boron neutron capture therapy for malignant melanoma: First clinical case report in China","volume":"28","author":"Yong","year":"2016","journal-title":"Chin. J. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1054\/bjoc.2000.1148","article-title":"Boron microlocalization in oral mucosal tissue: Implications for boron neutron capture therapy","volume":"82","author":"Morris","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3579742","article-title":"The radiation biology of boron neutron capture therapy","volume":"151","author":"Coderre","year":"1999","journal-title":"Radiat. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother. Oncol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:23:42Z","timestamp":1760167422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cells10112881"],"URL":"https:\/\/doi.org\/10.3390\/cells10112881","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]}}}